Literature DB >> 15611227

Plexin C1 engagement on mouse dendritic cells by viral semaphorin A39R induces actin cytoskeleton rearrangement and inhibits integrin-mediated adhesion and chemokine-induced migration.

Thierry Walzer1, Laurent Galibert, Michael R Comeau, Thibaut De Smedt.   

Abstract

The poxvirus A39R protein is a member of the semaphorin family previously reported to bind plexin C1. We show that, in the mouse, plexin C1 is expressed on dendritic cells (DCs) and neutrophils and is the only receptor for A39R on these cells. The biological effects of a recombinant form of A39R were examined in vitro on mouse DCs derived from wild-type or plexin C1(-/-) mice. A39R binding to plexin C1 on DCs inhibited integrin-mediated adhesion and spreading in vitro. This phenomenon was accompanied by a decrease in integrin signaling, measured by focal adhesion kinase phosphorylation, and a rearrangement of the actin cytoskeleton, without inducing DC maturation or affecting their viability. The A39R effect on DC adhesion was blocked by a specific inhibitor of cofilin phosphorylation, suggesting that the regulation of F-actin turnover by plexin C1 was essential to induce cellular retraction. Furthermore, A39R binding to plexin C1 inhibited chemokine-induced migration of DCs in vitro, suggesting that plexins and semaphorins could be involved in the regulation of leukocyte movement.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15611227     DOI: 10.4049/jimmunol.174.1.51

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  33 in total

Review 1.  Spatial organization of transmembrane receptor signalling.

Authors:  Ioanna Bethani; Sigrid S Skånland; Ivan Dikic; Amparo Acker-Palmer
Journal:  EMBO J       Date:  2010-08-18       Impact factor: 11.598

Review 2.  Regulation of immune cell responses by semaphorins and their receptors.

Authors:  Hyota Takamatsu; Tatsusada Okuno; Atsushi Kumanogoh
Journal:  Cell Mol Immunol       Date:  2010-02-01       Impact factor: 11.530

Review 3.  R-ras as a key player for signaling pathway of plexins.

Authors:  Manabu Negishi; Izumi Oinuma; Hironori Katoh
Journal:  Mol Neurobiol       Date:  2005-12       Impact factor: 5.590

Review 4.  Drinking a lot is good for dendritic cells.

Authors:  Christopher C Norbury
Journal:  Immunology       Date:  2006-04       Impact factor: 7.397

5.  Different requirement for Rnd GTPases of R-Ras GAP activity of Plexin-C1 and Plexin-D1.

Authors:  Kanami Uesugi; Izumi Oinuma; Hironori Katoh; Manabu Negishi
Journal:  J Biol Chem       Date:  2009-01-09       Impact factor: 5.157

Review 6.  Plexin structures are coming: opportunities for multilevel investigations of semaphorin guidance receptors, their cell signaling mechanisms, and functions.

Authors:  Prasanta K Hota; Matthias Buck
Journal:  Cell Mol Life Sci       Date:  2012-06-29       Impact factor: 9.261

7.  Semaphorin signaling in morphogenesis: found in translation.

Authors:  Andrew D Chisholm
Journal:  Genes Dev       Date:  2008-04-15       Impact factor: 11.361

8.  The genetic profiling of preferentially expressed genes in murine splenic CD8α+ dendritic cells.

Authors:  Tao Li; Wu-Ying Li; Hui-Ling Bai; Hong-Bing Ma; Hu Zhang; Jiang-Mu Zhu; Xiao-Hong Li; Hong-Ying Huang; Yuan-Fang Ma; Xin-Ying Ji
Journal:  Immunol Res       Date:  2011-10       Impact factor: 2.829

9.  Class 3 semaphorins induce F-actin reorganization in human dendritic cells: Role in cell migration.

Authors:  Sabrina Curreli; Bin Sheng Wong; Olga Latinovic; Konstantinos Konstantopoulos; Nicholas M Stamatos
Journal:  J Leukoc Biol       Date:  2016-07-12       Impact factor: 4.962

10.  The CD100 receptor interacts with its plexin B2 ligand to regulate epidermal γδ T cell function.

Authors:  Deborah A Witherden; Megumi Watanabe; Olivia Garijo; Stephanie E Rieder; Gor Sarkisyan; Shane J F Cronin; Petra Verdino; Ian A Wilson; Atsushi Kumanogoh; Hitoshi Kikutani; Luc Teyton; Wolfgang H Fischer; Wendy L Havran
Journal:  Immunity       Date:  2012-08-16       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.